Tech Mahindra: This company’s stock is now among the most overbought IT services companies among the Nifty 500, according to technical indicators like RSI and MFI. The company’s stock rose a little over 26% after it announced its Q1FY22 results at the end of July. The company’s over 4% dollar revenue growth enthused investors, which has pushed its TTM PE ratio to its highest ever at 25.2. 

ICICI Bank: This private bank’s shares received the highest number of target price upgrades (seven) over the past one month as analysts were enthused by its performance in Q1FY21. The bank posted a 50% YoY rise in its Q1FY22 profit at Rs 4,747.4 crore on the back of a 5bps expansion in its net interest margin to 3.89% and a 20% YoY growth in retail loans. The stock ended Tuesday’s trade within 2.2% of its average target price of Rs 701.20.

Aurobindo Pharma: This pharma company’s stock was on a falling spree even before its results were announced last Thursday. In the past three weeks, the stock has fallen nearly 20%, with nearly 11% of the fall coming after the company declared its results. It was the only stock that touched a 52-week low on Tuesday. The company’s net profits fell nearly 4% QoQ in Q1FY22 to Rs 770 crore, while revenues fell nearly 4.9% QoQ to Rs 5,783.3 crore. A slowdown in the company’s US business due to delays in product launches amid a third wave of the pandemic and lower sales of anti-retrovirals doesn't bode well. As the company’s stock kept falling over the previous three weeks, many promoter entities had to pledge an additional 1.28% of their stake in the company over the last few days as collateral for loans taken by those entities.

KEI Industries: Over the past three months, this electrical products maker’s stock rose nearly 46% and touched a 52-week high of Rs 783.7. This company was severely impacted by the first wave of the pandemic in Q1FY21 and its profits fell by 20% YoY. The company’s profits rose rapidly over the next three quarters, which helped it post a higher profit in FY21 than FY20,  despite the impact of the first wave. Q1FY22 however, disappointed even though the impact of the second wave was not as severe, the company’s net profit fell nearly 25% to Rs 67 crore. Promoter Anil Gupta cashed in on this frenzy in the share price of the company, and from June 18, 2021 to August 16, 2021, pared his holdings through multiple sales by 1.59% to 13.64%.

Apollo Hospital Enterprises: This hospital chain company’s stock was the best performing stock among the Nifty 500 and gained the most on Tuesday, rising 13.2%. It also gained nearly 23% over the past week. On Friday, the company announced that its profits nearly tripled QoQ in Q1FY22, despite a mere 31% rise in its revenues.